Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria R. Baer"'
Autor:
Manish R. Patel, William Donnellan, Michael Byrne, Adam S. Asch, Amer M. Zeidan, Maria R. Baer, Amir T. Fathi, Andrew T. Kuykendall, Fred Zheng, Chris Walker, Lulu Cheng, Cindy Marando, Michael R. Savona
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Autor:
Gabriela Sanchez-Petitto, Olga G. Goloubeva, Jack Masur, James Childress, Tahreem Iqbal, Max An, Safwan Muhammad, Justin Lawson, Brian Barr, Ashkan Emadi, Jennie Law, Vu H. Duong, Maria R. Baer, Sandrine Niyongere
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S242-S243
Autor:
Gabriela Sanchez-Petitto, Olga G. Goloubeva, Jack Masur, James Childress, Tahreem Iqbal, Max An, Safwan Muhammad, Justin Lawson, Brian Barr, Ashkan Emadi, Jennie Law, Vu H. Duong, Maria R. Baer, Sandrine Niyongere
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S134
Autor:
Max An, Justin Lawson, Muhammad Safwan, Sandrine Niyongere, Maria R. Baer, Tahreem Iqbal, Vu H. Duong, Jennie Y. Law, Brian Barr, Gabriela Sanchez-Petitto, Michael E. Kallen, Ashkan Emadi, James Childress, Madhurima Koka, Jack Masur, Olga Goloubeva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S350-S351
Context: The incidence of both myeloid malignancies and cardiovascular disease (CVD) increases with age. We aimed to study whether the presence of CVD is associated with worse outcomes in patients with myeloid malignancies and to delineate a possible
Autor:
Gabriela Sanchez-Petitto, Michael Kallen, Madhurima Koka, Olga Goloubeva, Jack Masur, Max An, James Childress, Tahreem Iqbal, Muhammad Safwan, Justin Lawson, Brian Barr, Vu H. Duong, Jennie Y. Law, Ashkan Emadi, Maria R. Baer, Sandrine Niyongere
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S229
Autor:
Andrew H. Wei, Jacqueline S. Garcia, Uma Borate, Chun Yew Fong, Maria R Baer, Daniel Nowak, Pierre Peterlin, Joseph Jurcic, Meagan A. Jacoby, Uwe Platzbecker, Olatoyosi Odenike, Ilona Cunningham, Ying Zhou, David Hoffman, Leah Hogdal, Kiran Naqvi, Steve Kye, Guillermo Garcia-Manero
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S227
Autor:
Joseph G. Jurcic, Ilona Cunningham, Maria R. Baer, Olatoyosi Odenike, Guillermo Garcia-Manero, Kiran Naqvi, Uma Borate, David Hoffman, Steve Kye, Uwe Platzbecker, Meagan A. Jacoby, Pierre Peterlin, Leah Hogdal, Andrew H. Wei, Ying Zhou, Chun Yew Fong, Jacqueline S. Garcia, Daniel Nowak
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S343
Background: Venetoclax (Ven), a selective oral BCL-2 inhibitor, demonstrated synergy with azacitidine (Aza) in patients with higher-risk myelodysplastic syndromes (HR-MDS). Objective: We report updated safety and efficacy in an ongoing phase 1b study
Autor:
Chun Yew Fong, Jason Harb, Johannes E. A. Wolff, Jacqueline S. Garcia, Guillermo Garcia-Manero, Ying Zhou, Poonam Tanwani, Meagan A. Jacoby, Uwe Platzbecker, Uma Borate, Relja Popovic, Pierre Peterlin, Joseph G. Jurcic, Ilona Cunningham, Florian Nolte, Sathej Gopalakrishnan, Maria R. Baer, Andrew H. Wei, Olatoyosi Odenike, Wan-Jen Hong, Martin Dunbar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S315-S316
Background/Aims: Venetoclax (Ven), a selective oral BCL-2 inhibitor, has shown synergy with hypomethylating agents (HMAs) such as Azacitidine (Aza), in treatment of higher-risk myelodysplastic syndrome (HR)-MDS. We evaluate prognostic impact of cytog
Autor:
Mitchell Garrison, Jeannine S. McCune, Barry E. Storer, Selina M. Luger, Frederick R. Appelbaum, Tanya M. Wildes, Brenda M. Sandmaier, Andrew M. Brunner, Kehinde Adekola, Pamela S. Becker, Mikkael A. Sekeres, Elihu H. Estey, David A. Rizzieri, Bruno C. Medeiros, Wendy Leisinring, Paul J. Shami, Jamie Koprivnikar, Mohamed L. Sorror, Maria R. Baer, Lynn Onstad, Eunice S. Wang, Kiarash Kojouri, Tammy Schuler, Stephanie J. Lee, Aaron T. Gerds, Amir T. Fathi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S185
Context Acute myeloid leukemia (AML) has a median survival of 6-12 months, with no major improvement over the last two decades. AML is a disease of elderly patients. Less-intensive induction therapies increasingly used in older patients, presuming th
Autor:
Rajul K. Jain, Michael R. Bishop, John M. Rossi, William G. Wierda, Houston Holmes, Allen Xue, Tong Shen, Remus Vezan, Kristen M. O'Dwyer, Olalekan O. Oluwole, William B. Donnellan, Bijal D. Shah, Armen Mardiros, Maria R. Baer, Gary J. Schiller
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S184